ArticleCancer diagnosis & prognosis
Clinical Outcomes of Adrenalectomy for Metastatic Adrenal Tumor: A 30-case Single-center Study.
Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aim: The adrenal gland is a common site of metastasis from various primary malignancies, and adrenalectomy may provide long-term survival benefits in carefully selected patients. However, prognostic factors influencing overall survival (OS) after adrenalectomy for metastatic adrenal tumors remain insufficiently defined. In addition, the optimal surgical approach - particularly the appropriateness of laparoscopic Patients and Methods: We retrospectively analyzed 30 patients who underwent adrenalectomy for metastatic adrenal tumors at a single institution between November 2006 and March 2025. Clinicopathological features, perioperative outcomes, and OS were evaluated. To examine differences in surgical invasiveness and prognosis, patients were stratified by tumor size (<5 cm Results: The median tumor size was 2.6 cm, and 93% of patients underwent laparoscopic adrenalectomy. Extended adrenalectomy was required in 20%, and the open conversion rate was 7%. Patients with tumors ≥5 cm exhibited longer operative time, greater blood loss, higher rates of extended adrenalectomy and open conversion, and more frequent perioperative complications. The median OS for the entire cohort was 130 months. Patients with tumors ≥5 cm had significantly worse OS (log-rank Conclusion: Adrenalectomy can achieve favorable long-term survival in selected patients with adrenal metastasis. Laparoscopic adrenalectomy is an effective minimally invasive option for tumors <5 cm, whereas tumors ≥5 cm are associated with greater surgical invasiveness and poorer prognosis, necessitating careful operative planning and consideration of open adrenalectomy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.